Enrich Therapeutics reports that the company had been awarded a 12-month Small Business Innovation Research (SBIR) research contract from the National Cancer Institute.
The contract is intended to accelerate the development of advanced sample processing platforms for downstream single-cell multi-omic analysis. The project will be performed in collaboration with Dr. Kien Pham’s team at Yale.